Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.75    -0.065 (-1.35%)
Bid:
4.72
Ask:
4.785
Spread: 0.065 (1.377%)
Market Cap: £227.98m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Change

8 Jun 2011 07:00

RNS Number : 0183I
Seeing Machines Limited
08 June 2011
 



8 June 2011

SEEING MACHINES (the "Company")

 

CEO TO DEPART AT END OF CONTRACT

Seeing Machines Limited (AIM:SEE), a leading developer of advanced vision based industrial systems, announces today that CEO and Director Dr Nick Cerneaz will leave the Company in July 2011.

Dr Cerneaz has been with the Company since 2005 and took over as CEO in September 2005 and led the Company at the time of its listing on AIM in December 2005. For the six years that he has been with the company he has commuted to the Canberra head office from his home in Sydney where he lives with his wife and young family. Dr Cerneaz and the Board of Seeing Machines have agreed his tenure as CEO will conclude at the end of this contract. Dr Cerneaz has also agreed to assist the Company in a consulting capacity throughout a handover period as required.

The Board is currently conducting a search for a replacement to lead the Company, as it seeks to move through the next phase of growth and commercialisation. Seeing Machines manufactures a range of world leading products from fatigue management tools through to 3D visualisation and medical technologies, and the Board remains committed to driving a strategy of growth through commercialisation of these technologies and products.

Dr Cerneaz commented: "I have very much enjoyed the efforts and contribution I have made at Seeing Machines and greatly valued the opportunity to work with such a dedicated, professional and energetic team. We have successfully moved the Company through an extensive period of development and laid the foundations for tremendous commercial success ahead, particularly with significant contracts established in our DSS and faceAPI businesses and strong pipelines ahead. I wish to take this opportunity to thank all my colleagues and the stakeholders in the business that have encouraged and supported our efforts and wish the company well in its forward endeavours."

Chairman Bill Mobbs commenting on Dr Cerneaz's departure said: "The Board is extremely grateful to Nick for his leadership of the Company throughout his tenure which was characterised by strong commitment, professionalism, drive and enthusiasm in taking the Company forward. We wish Nick well in his future endeavours and join with everyone at Seeing Machines in thanking Nick wholeheartedly for his efforts on behalf of the Company. "

Enquiries:

Seeing Machines Limited

Bill Mobbs, Chairman

+61 (0) 2 6103 4700

Daniel Stewart & Company plc

Oliver Rigby

+44 (0) 20 7776 6550

Walbrook PR Ltd

 

Paul McManus

 

Paul Cornelius

+44 (0) 20 7933 8780+44 (0) 7980 541 893, paul.mcmanus@walbrookpr.com

+44 (0) 7866 384 707, paul.cornelius@walbrookir.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGMGGVDNRGMZM
Date   Source Headline
10th Jun 20197:00 amRNSSelf-driving car company signs Guardian BdMS deal
7th Jun 201911:49 amRNSHolding(s) in Company
6th Jun 201912:53 pmRNSHolding(s) in Company
5th Jun 20191:03 pmRNSSenior Leadership Transition
16th May 20197:00 amRNSFleet Update
30th Apr 20192:58 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirectorate Change
25th Apr 201910:18 amRNSHolding(s) in Company
23rd Apr 20198:34 amRNSResult of GM, Offer and Total Voting Rights
10th Apr 20197:00 amRNSAutomotive deal with Joyson for US OEM
5th Apr 20197:00 amRNSSeeing Machines partners with Australian insurer
2nd Apr 201912:01 pmRNSIssue of Equity and Total Voting Rights
25th Mar 20192:00 pmRNSPosting of Offer Documents & Notice of GM
22nd Mar 20197:00 amRNSSubscription by Directors & Senior Management
20th Mar 201911:35 amRNSConditional Placing & Subscription to raise £27.5m
20th Mar 201911:29 amRNSHalf-year Report to 31 December 2018
8th Mar 20197:00 amRNSEye tracking technology trial with Toll
22nd Feb 20198:30 amRNSEU mandates safety technology for vehicles
19th Feb 20197:00 amRNSSixth Automotive OEM Design Win
16th Jan 20197:00 amRNSHalf year trading update
14th Jan 20197:00 amRNSCadillac Super Cruise 2019 Technology of the Year
13th Dec 20187:00 amRNSBoard Changes
12th Dec 20187:00 amRNSCollaboration with L3 to deliver eye tracking
6th Dec 20182:33 pmRNSIssue of Shares and Total Voting Rights
3rd Dec 20187:00 amRNSLuke Oxenham appointed Chief Financial Officer
26th Nov 20187:00 amRNSAviation division signs deal with Air Force
23rd Nov 20187:00 amRNSChief Financial Officer
16th Nov 20187:00 amRNSAppoints Paul McGlone to head Fleet division
14th Nov 20187:00 amRNSResult of AGM
14th Nov 20187:00 amRNSAGM Statement
22nd Oct 201810:27 amRNSNotice of AGM
17th Oct 20187:00 amRNSSeeing Machines appoints Ryan Murphy as COO
28th Sep 201811:05 amRNSIssue of Shares
19th Sep 20187:00 amRNSYear end results
11th Sep 20187:00 amRNSSeeing Machines launches Guardian BdMS
4th Sep 20182:06 pmRNSSecond Price Monitoring Extn
4th Sep 20182:00 pmRNSPrice Monitoring Extension
4th Sep 201811:05 amRNSSecond Price Monitoring Extn
4th Sep 201811:00 amRNSPrice Monitoring Extension
4th Sep 201810:19 amRNSSeeing Machines Limited Fleet Business Unit Update
29th Aug 20187:00 amRNSGuardian DMS covers more than 1 billion km
23rd Aug 201812:02 pmRNSTransfer of Ordinary Shares
16th Aug 201811:09 amRNSHolding(s) in Company
15th Aug 20189:41 amRNSIssue of Shares for Vested Performance Rights
9th Aug 20187:00 amRNSSeeing Machines leads pilot training collaboration
3rd Aug 20187:00 amRNSYear end trading update
27th Jul 20187:00 amRNSOEM Design Award
16th Jul 20187:00 amRNSBoard changes
5th Jul 20187:00 amRNSUS Fleet (Guardian) Contract
28th Jun 20181:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.